透析患者ST段抬高型心肌梗死直接PCI的治疗效果
本研究基于美国全国住院患者样本(2016-2018)的回顾性队列,比较维持性透析与非透析的STEMI患者接受直接PCI的院内结局。透析患者接受直接PCI的比例较低(57.5% vs 79.8%),但直接PCI在透析与非透析患者中均与死亡率降低相关,且治疗效应无显著差异(交互P=0.9)。
要点
- 透析患者STEMI后接受直接PCI的比例显著低于非透析患者。
- 直接PCI在透析与非透析患者中均与院内死亡率降低相关。
- 直接PCI对死亡率的治疗效应不受透析状态显著修饰。
核心结论
- 与非保守治疗相比,直接PCI在透析与非透析STEMI患者中均与短期死亡率降低相关,且效应无显著差异。
研究设计与样本
- 回顾性队列研究,使用美国全国住院患者样本(2016-2018),纳入所有成人STEMI住院患者。
主要发现
- 透析住院患者占413,500例中的4,220例(1.07%)。
- 透析患者行动脉造影的比例为73.1% vs 非透析85.4%(P < 0.001),直接PCI比例为57.5% vs 79.8%(P < 0.001)。
- 透析患者接受直接PCI的死亡率为15.7% vs 未接受PCI 27.1%(P < 0.001);非透析患者为5.0% vs 17.4%(P < 0.001)。
- 倾向评分匹配后,直接PCI对死亡率的平均治疗效应在透析组为-8.6%(95% CI, -15.6% to -1.6%),非透析组为-8.2%(95% CI, -8.8% to -7.5%),交互P=0.9。
- 平均边际效应在透析组为-9.4%(95% CI, -14.8% to -4.0%),非透析组为-7.9%(95% CI, -8.5% to -7.4%),交互P=0.6。
临床怎么用
- 对于维持性透析的STEMI患者,直接PCI可考虑作为降低短期死亡率的治疗选择。
局限性
- 使用行政数据,缺乏药物治疗和长期结局数据,存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Patients receiving maintenance dialysis have higher mortality after primary percutaneous coronary intervention (pPCI) than patients not receiving dialysis. Whether pPCI confers a benefit to patients receiving dialysis that is similar to that which occurs in lower-risk groups remains unknown. We compared the effect of pPCI on in-hospital outcomes among patients hospitalized for ST-elevation myocardial infarction (STEMI) and receiving maintenance dialysis with the effect among patients hospitalized for STEMI but not receiving dialysis. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: We used the National Inpatient Sample (2016-2018) and included all adult hospitalizations with a primary diagnosis of STEMI. PREDICTORS: Primary exposure was PCI. Confounders included dialysis status, demographics, insurance, household income, comorbidities, and the elective nature of the admission. OUTCOME: In-hospital mortality, stroke, acute kidney injury, new dialysis requirement, vascular complications, gastrointestinal bleeding, blood transfusion, mechanical ventilation, palliative care, and discharge destination. ANALYTICAL APPROACH: The average treatment effect (ATE) of pPCI was estimated using propensity score matching independently within the group receiving dialysis and the group not receiving dialysis to explore whether the effect is modified by dialysis status. Additionally, the average marginal effect (AME) was calculated accounting for the clustering within hospitals. RESULTS: Among hospitalizations, 4,220 (1.07%) out of 413,500 were for patients receiving dialysis. The dialysis cohort was older (65.2 ± 12.2 vs 63.4 ± 13.1, P < 0.001), had a higher proportion of women (42.4% vs 30.6%, P < 0.001) and more comorbidities, and had a lower proportion of White patients (41.1% vs 71.7%, P < 0.001). Patients receiving dialysis were less likely to undergo angiography (73.1% vs 85.4%, P < 0.001) or pPCI (57.5% vs 79.8%, P < 0.001). Primary PCI was associated with lower mortality in patients receiving dialysis (15.7% vs 27.1%, P < 0.001) as well as in those who were not (5.0% vs 17.4%, P < 0.001). The ATE on mortality did not differ significantly (P interaction = 0.9) between patients receiving dialysis (-8.6% [95% CI, -15.6% to -1.6%], P = 0.02) and those who were not (-8.2% [95% CI, -8.8% to -7.5%], P < 0.001). The AME method showed similar results among patients receiving dialysis (-9.4% [95% CI, -14.8% to -4.0%], P < 0.001) and those who were not (-7.9% [95% CI, -8.5% to -7.4%], P < 0.001) (P interaction = 0.6). Both the ATE and AME were comparable for other in-hospital outcomes in both groups. LIMITATIONS: Administrative data, lack of pharmacotherapy and long-term outcome data, and residual confounding. CONCLUSIONS: Compared with conservative management, pPCI for STEMI was associated with comparable reductions in short-term mortality among patients irrespective of their receipt of maintenance dialysis.
引用
- Kawsara A, Sulaiman S, Mohamed M, et al. Treatment Effect of Percutaneous Coronary Intervention in Dialysis Patients With ST-Elevation Myocardial Infarction. Am J Kidney Dis. 2021. PMID: 34662690. doi:10.1053/j.ajkd.2021.08.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。